Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response

Toshiki Yajima, Hitoshi Nishimura, Worawidh Wajjwalku, Mamoru Harada, Hiroyuki Kuwano, Yasunobu Yoshikai

    Research output: Contribution to journalArticle

    48 Citations (Scopus)

    Abstract

    Interleukin (IL)-15, a pleiotropic cytokine, is involved in the development and maintenance of NK cells and memory CD8+ T cells. We examined the effects of in vivo overexpression of IL-15 on protection against 2 types of murine B16 melanoma lines, MHC class I-negative B16.44 and MHC class I-positive B16F10 cells, using IL-15 transgenic (Tg) mice that we have recently constructed. The tumor growth was severely retarded in IL-15 Tg mice after subcutaneous (s.c.) inoculation with B16.44 or B16F10 cells. IL-15 Tg mice showed an augmented NK cell activity against B16.44 cells, and in vivo depletion of NK cells by anti-asialoGMI Ab treatment abrogated the antitumor activity in IL-15 Tg mice. On the other hand, IL- 15 Tg mice inoculated with B16F10 cells developed a significant level of CTL response against B16F10 cells, and in vivo depletion of CD8+ T cells by anti-CD8 MAb treatment abrogated the antitumor activity. Thus, overexpression of IL-15 augmented antitumor activity against different tumors via augmentation of different antitumor mechanisms. These results suggest a possible therapeutic application of IL-15 for human neoplasms expressing a wide range of MHC class molecules.

    Original languageEnglish
    Pages (from-to)573-578
    Number of pages6
    JournalInternational Journal of Cancer
    Volume99
    Issue number4
    DOIs
    Publication statusPublished - Jun 1 2002

    Fingerprint

    Interleukin-15
    Melanoma
    T-Lymphocytes
    Transgenic Mice
    Natural Killer Cells
    Neoplasms
    Experimental Melanomas
    Maintenance
    Cytokines
    Growth

    All Science Journal Classification (ASJC) codes

    • Oncology
    • Cancer Research

    Cite this

    Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. / Yajima, Toshiki; Nishimura, Hitoshi; Wajjwalku, Worawidh; Harada, Mamoru; Kuwano, Hiroyuki; Yoshikai, Yasunobu.

    In: International Journal of Cancer, Vol. 99, No. 4, 01.06.2002, p. 573-578.

    Research output: Contribution to journalArticle

    Yajima, Toshiki ; Nishimura, Hitoshi ; Wajjwalku, Worawidh ; Harada, Mamoru ; Kuwano, Hiroyuki ; Yoshikai, Yasunobu. / Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. In: International Journal of Cancer. 2002 ; Vol. 99, No. 4. pp. 573-578.
    @article{a325d07ab0364958852d5cd318b1ea3e,
    title = "Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response",
    abstract = "Interleukin (IL)-15, a pleiotropic cytokine, is involved in the development and maintenance of NK cells and memory CD8+ T cells. We examined the effects of in vivo overexpression of IL-15 on protection against 2 types of murine B16 melanoma lines, MHC class I-negative B16.44 and MHC class I-positive B16F10 cells, using IL-15 transgenic (Tg) mice that we have recently constructed. The tumor growth was severely retarded in IL-15 Tg mice after subcutaneous (s.c.) inoculation with B16.44 or B16F10 cells. IL-15 Tg mice showed an augmented NK cell activity against B16.44 cells, and in vivo depletion of NK cells by anti-asialoGMI Ab treatment abrogated the antitumor activity in IL-15 Tg mice. On the other hand, IL- 15 Tg mice inoculated with B16F10 cells developed a significant level of CTL response against B16F10 cells, and in vivo depletion of CD8+ T cells by anti-CD8 MAb treatment abrogated the antitumor activity. Thus, overexpression of IL-15 augmented antitumor activity against different tumors via augmentation of different antitumor mechanisms. These results suggest a possible therapeutic application of IL-15 for human neoplasms expressing a wide range of MHC class molecules.",
    author = "Toshiki Yajima and Hitoshi Nishimura and Worawidh Wajjwalku and Mamoru Harada and Hiroyuki Kuwano and Yasunobu Yoshikai",
    year = "2002",
    month = "6",
    day = "1",
    doi = "10.1002/ijc.10395",
    language = "English",
    volume = "99",
    pages = "573--578",
    journal = "International Journal of Cancer",
    issn = "0020-7136",
    publisher = "Wiley-Liss Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response

    AU - Yajima, Toshiki

    AU - Nishimura, Hitoshi

    AU - Wajjwalku, Worawidh

    AU - Harada, Mamoru

    AU - Kuwano, Hiroyuki

    AU - Yoshikai, Yasunobu

    PY - 2002/6/1

    Y1 - 2002/6/1

    N2 - Interleukin (IL)-15, a pleiotropic cytokine, is involved in the development and maintenance of NK cells and memory CD8+ T cells. We examined the effects of in vivo overexpression of IL-15 on protection against 2 types of murine B16 melanoma lines, MHC class I-negative B16.44 and MHC class I-positive B16F10 cells, using IL-15 transgenic (Tg) mice that we have recently constructed. The tumor growth was severely retarded in IL-15 Tg mice after subcutaneous (s.c.) inoculation with B16.44 or B16F10 cells. IL-15 Tg mice showed an augmented NK cell activity against B16.44 cells, and in vivo depletion of NK cells by anti-asialoGMI Ab treatment abrogated the antitumor activity in IL-15 Tg mice. On the other hand, IL- 15 Tg mice inoculated with B16F10 cells developed a significant level of CTL response against B16F10 cells, and in vivo depletion of CD8+ T cells by anti-CD8 MAb treatment abrogated the antitumor activity. Thus, overexpression of IL-15 augmented antitumor activity against different tumors via augmentation of different antitumor mechanisms. These results suggest a possible therapeutic application of IL-15 for human neoplasms expressing a wide range of MHC class molecules.

    AB - Interleukin (IL)-15, a pleiotropic cytokine, is involved in the development and maintenance of NK cells and memory CD8+ T cells. We examined the effects of in vivo overexpression of IL-15 on protection against 2 types of murine B16 melanoma lines, MHC class I-negative B16.44 and MHC class I-positive B16F10 cells, using IL-15 transgenic (Tg) mice that we have recently constructed. The tumor growth was severely retarded in IL-15 Tg mice after subcutaneous (s.c.) inoculation with B16.44 or B16F10 cells. IL-15 Tg mice showed an augmented NK cell activity against B16.44 cells, and in vivo depletion of NK cells by anti-asialoGMI Ab treatment abrogated the antitumor activity in IL-15 Tg mice. On the other hand, IL- 15 Tg mice inoculated with B16F10 cells developed a significant level of CTL response against B16F10 cells, and in vivo depletion of CD8+ T cells by anti-CD8 MAb treatment abrogated the antitumor activity. Thus, overexpression of IL-15 augmented antitumor activity against different tumors via augmentation of different antitumor mechanisms. These results suggest a possible therapeutic application of IL-15 for human neoplasms expressing a wide range of MHC class molecules.

    UR - http://www.scopus.com/inward/record.url?scp=0036605090&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0036605090&partnerID=8YFLogxK

    U2 - 10.1002/ijc.10395

    DO - 10.1002/ijc.10395

    M3 - Article

    C2 - 11992548

    AN - SCOPUS:0036605090

    VL - 99

    SP - 573

    EP - 578

    JO - International Journal of Cancer

    JF - International Journal of Cancer

    SN - 0020-7136

    IS - 4

    ER -